ly 163443 has been researched along with verlukast in 1 studies
| Studies (ly 163443) | Trials (ly 163443) | Recent Studies (post-2010) (ly 163443) | Studies (verlukast) | Trials (verlukast) | Recent Studies (post-2010) (verlukast) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 396 | 14 | 115 |
| Protein | Taxonomy | ly 163443 (IC50) | verlukast (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 2.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denzlinger, C; Grimberg, M; Haberl, C; Kapp, A; Wilmanns, W | 1 |
1 other study(ies) available for ly 163443 and verlukast
| Article | Year |
|---|---|
Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
Topics: Acetophenones; Animals; Bile; Chromatography, High Pressure Liquid; Chromones; Leukotrienes; Male; Propionates; Quinolines; Radioimmunoassay; Rats; Rats, Inbred Strains; SRS-A | 1991 |